公共信息 公共信息
HOME
ABOUT US
TEAM
INVESTMENT
ESG
NEWS & MEDIA
CONTACT US
CN/ EN
GL Capital Leads Chinese Healthcare Companies in Exploring Southeast Asia Market Opportunities
2024 / 09 - 13
GL Capital Leads Chinese Healthcare Companies in Exploring Southeast Asia Market Opportunities
GL Capital, a leading private equity firm focusing on healthcare investment in China, has spearheaded Chinese healthcare companies' foray into Southeast Asia, conducting a week-long Southeast Asia-China Healthcare Summit and business exploration from September 5th to 10th. The event wa...
Learn More
GL Capital leads a significant minority investment in Sangon Biotech, a leading supplier of life science research products and services in China
2023 / 04 - 19
GL Capital leads a significant minority investment in Sangon Biotech, a leading supplier of life science research products and services in China
A consortium led by GL Capital Group ("GL Capital”), a leading healthcare-focused private equity firm, has made a significant minority investment in Sangon Biotech (Shanghai) Co., Ltd ("Sangon Biotech" or "Sangon" or "the Company"). Founded in 1995, Sangon Biotech...
Learn More
GL Capital acquires controlling stake in Foryou Medical, a leading advanced wound care CDMO
2023 / 03 - 18
GL Capital acquires controlling stake in Foryou Medical, a leading advanced wound care CDMO
GL Capital Group (“GL Capital”), a leading healthcare-focused private equity firm, and Huizhou Foryou Medical Devices Co., Ltd (“Foryou Medical” or “the Company”) have signed an agreement for a GL Capital-led consortium to acquire a majority stake in Foryou Medical. Founded in 2005, Foryou Med...
Learn More
GL Capital Leads Chinese Healthcare Companies in Exploring Southeast Asia Market Opportunities
GL Capital Leads Chinese Healthcare Companies in Exploring Southeast Asia Market Opportunities

GL Capital, a leading private equity firm focusing on healthcare investment in China, has spearheaded Chinese healthcare companies' foray into Southeast Asia, conducting a week-long Southeast Asia-China Healthcare Summit and business exploration from September 5th to 10th. The event wa...

Learn More
13
2024/09-
GL Capital leads a significant minority investment in Sangon Biotech, a leading supplier of life science research products and services in China
GL Capital leads a significant minority investment in Sangon Biotech, a leading supplier of life science research products and services in China

A consortium led by GL Capital Group ("GL Capital”), a leading healthcare-focused private equity firm, has made a significant minority investment in Sangon Biotech (Shanghai) Co., Ltd ("Sangon Biotech" or "Sangon" or "the Company"). Founded in 1995, Sangon Biotech...

Learn More
19
2023/04-
GL Capital acquires controlling stake in Foryou Medical, a leading advanced wound care CDMO
GL Capital acquires controlling stake in Foryou Medical, a leading advanced wound care CDMO

GL Capital Group (“GL Capital”), a leading healthcare-focused private equity firm, and Huizhou Foryou Medical Devices Co., Ltd (“Foryou Medical” or “the Company”) have signed an agreement for a GL Capital-led consortium to acquire a majority stake in Foryou Medical. Founded in 2005, Foryou Med...

Learn More
18
2023/03-
公共信息
ABOUT US
INVESTMENT
NEWS & MEDIA
CONTACT US
Contact Us :
Telephone +86 10 5961 1212
Fax +86 10 5961 1210
Email info@gl-investment.com
Investor Relations ir@gl-investment.com

Legal Statement: Beijing ICP 2021006157
Copyright @ 2024 GL Capital. All righ